A 44-year-old man with suspected exacerbation of COPD and atrial fibrillation

Chest

Volumn 125, Issue 6, 2004, Pages 2340-2344

  Ramanuja, Srinivasan ^a   Mastronarde, John ^a   Dowdeswell, Ian ^a   Kamalesh, Masoor ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIGOXIN; DILTIAZEM; DIURETIC AGENT; FUROSEMIDE; GATIFLOXACIN; SALBUTAMOL; SALMETEROL;

ADULT; ANAMNESIS; ARTICLE; ASSISTED VENTILATION; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HEMODYNAMIC MONITORING; HUMAN; LABORATORY TEST; MALE; MITRAL VALVE STENOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SMOKING HABIT; THORAX RADIOGRAPHY;

EID: 2942707642     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2340     Document Type: Article

References (12)

1. Abascal VM, Wilkins GT, Choong CY, et al. Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol 1988; 12:606-615
2. Carabello BA, Crawford FA Jr. Medical progress: valvular heart disease. N Engl J Med 1997; 337:32-41
3. Cheesman MG, Leech G, Chambers J, et al. Central role of echocardiography in the diagnosis and assessment of heart failure. BMJ 1998; 80:1S-5S
4. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362:316-322
5. George R, Subramanian N, Dhar SR. Significance of cardiac arrhythmias during acute exacerbation of COPD. Chest 2000; 118:193S-194S
6. Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000; 6:92-96
7. Latini R, Masson S, De Angelis N, et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. J Card Fail 2002; 8:288-299
8. Mair J, Friedl W, Thomas S, et al. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 1999; 59(suppl 230):132-142
9. Nour MM, Mustafa KY, Mousa K, et al. Reversible airway obstruction in rheumatic mitral valve disease. Respirology 1998; 3:25-31
10. Tharaux PL, Dussaule JC, Hubert-Brierre J, et al. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci 1994; 87:671-677
11. Woolley K, Stark P. Pulmonary parenchymal manifestations of mitral valve disease. Radiographics 1999; 19:965-972
12. Yoshioka T, Nakanishi N, Okubo S, et al. Improvement in pulmonary function in mitral stenosis after percutaneous transvenous mitral commissurotomy. Chest 1990; 98:290-294